Literature DB >> 12444194

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma.

Andreas Geier, Carsten Gartung, Christoph G Dietrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12444194     DOI： 10.1056/NEJM200211213472119

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China.

Authors:  Yanbing Zeng; Mingliang Luo; Jianlin Lin; Hanqing He; Xuan Deng; Shuyun Xie; Ya Fang
Journal:  Hum Vaccin Immunother       Date:  2019-11-26       Impact factor: 3.452

Review 2.  Hepatitis B: Working Towards a Cure.

Authors:  Bianca W Chang; Aung Kaung; Lori Robbins; Tram T Tran
Journal:  Curr Gastroenterol Rep       Date:  2015-09

3.  Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.

Authors:  Guoyi Wu; Bo Liu; Yingjun Zhang; Jing Li; Alla Arzumanyan; Marcia M Clayton; Raymond F Schinazi; Zhaohe Wang; Siegfried Goldmann; Qingyun Ren; Faxhou Zhang; Mark A Feitelson
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

4.  Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population.

Authors:  Lifeng Liu; Jinjian Yao; Jin Li; Jinliang Zhang; Jinling Yu; Xiaorui Jiang; Shuzhen Sun; Qing Liu; Ying Chang; Yongwen He; Jusheng Lin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

5.  Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii.

Authors:  Naoky C S Tsai; Peter S Holck; Linda L Wong; Aldrich A Ricalde
Journal:  Hepatol Int       Date:  2008-10-15       Impact factor: 6.047

Review 6.  DNA-guided hepatitis B treatment, viral load is essential, but not sufficient.

Authors:  Rafael Bárcena Marugán; Silvia García Garzón
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

7.  HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.

Authors:  Peng Liu; Hualin Zhang; Xiaohong Liang; Hongxin Ma; Fang Luan; Bo Wang; Fuxiang Bai; Lifen Gao; Chunhong Ma
Journal:  Oncotarget       Date:  2015-10-06

Review 8.  Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-Analysis.

Authors:  Xiang Lyu; Kui Liu; Yongdi Chen; Zhifang Wang; Jun Yao; Gaofeng Cai; Zhenggang Jiang; Zhengting Wang; Jianmin Jiang; Hua Gu
Journal:  Int J Environ Res Public Health       Date:  2016-06-17       Impact factor: 3.390

Review 9.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.

Authors:  Ran Xu Zhu; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

10.  Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis.

Authors:  Sheng-Sen Chen; Kang-Kang Yu; Qing-Xia Ling; Chong Huang; Ning Li; Jian-Ming Zheng; Su-Xia Bao; Qi Cheng; Meng-Qi Zhu; Ming-Quan Chen
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.